Roche Holding Ltd. (NASDAQ:RHHBY) was downgraded by equities researchers at Deutsche Bank AG from a “buy” rating to a “hold” rating in a research note issued to investors on Friday.

Several other brokerages have also commented on RHHBY. Societe Generale lowered shares of Roche Holding from a “buy” rating to a “hold” rating in a research note on Friday, June 30th. Cowen and Company upgraded shares of Roche Holding from a “market perform” rating to an “outperform” rating and increased their price target for the stock from $25.25 to $33.37 in a research note on Wednesday, April 5th. BNP Paribas restated a “neutral” rating on shares of Roche Holding in a research note on Tuesday, June 20th. Liberum Capital initiated coverage on shares of Roche Holding in a research note on Thursday, March 9th. They set a “hold” rating on the stock. Finally, Zacks Investment Research lowered shares of Roche Holding from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, May 9th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $34.69.

Shares of Roche Holding (NASDAQ RHHBY) traded up 0.10% during mid-day trading on Friday, reaching $31.37. 2,294,972 shares of the company were exchanged. Roche Holding has a 12 month low of $25.25 and a 12 month high of $36.82. The firm’s 50-day moving average is $33.18 and its 200-day moving average is $31.38. The company has a market capitalization of $213.81 billion and a price-to-earnings ratio of 21.91.

COPYRIGHT VIOLATION WARNING: “Deutsche Bank AG Lowers Roche Holding Ltd. (RHHBY) to Hold” was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States and international trademark and copyright legislation. The original version of this story can be accessed at https://www.americanbankingnews.com/2017/07/07/deutsche-bank-ag-lowers-roche-holding-ltd-rhhby-to-hold.html.

Hedge funds and other institutional investors have recently made changes to their positions in the company. Fisher Asset Management LLC raised its position in shares of Roche Holding by 1.1% in the first quarter. Fisher Asset Management LLC now owns 15,104,940 shares of the company’s stock valued at $482,523,000 after buying an additional 158,482 shares during the period. Parametric Portfolio Associates LLC raised its position in shares of Roche Holding by 20.4% in the first quarter. Parametric Portfolio Associates LLC now owns 3,251,825 shares of the company’s stock valued at $104,156,000 after buying an additional 550,838 shares during the period. Schafer Cullen Capital Management Inc. raised its position in shares of Roche Holding by 10.8% in the first quarter. Schafer Cullen Capital Management Inc. now owns 2,369,119 shares of the company’s stock valued at $75,883,000 after buying an additional 230,620 shares during the period. Riverbridge Partners LLC raised its position in shares of Roche Holding by 6.0% in the first quarter. Riverbridge Partners LLC now owns 877,688 shares of the company’s stock valued at $28,037,000 after buying an additional 49,811 shares during the period. Finally, Moody Lynn & Lieberson LLC acquired a new position in shares of Roche Holding during the first quarter valued at approximately $11,158,000.

About Roche Holding

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (NASDAQ:RHHBY)

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.